A SMARCD2-containing mSWI/SNF complex is required for granulopoiesis
Crossref DOI link: https://doi.org/10.1038/ng.3853
Published Online: 2017-04-26
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Michel, Brittany C
Kadoch, Cigall http://orcid.org/0000-0002-4058-5985
Text and Data Mining valid from 2017-04-26
Version of Record valid from 2017-04-26
Article History
First Online: 26 April 2017
Competing interests
: C.K. is a scientific founder of Foghorn Therapeutics, Inc. (Cambridge, MA)